Climb Bio

CLYM · NASDAQ

$10.80+$1.07 (+11.00%)TodayMarket closed ·
Prev close $9.73

Who owns CLYM

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 67.7% of CLYM’s shares.

  • RA Capital Management, LP17.6%
  • Fidelity Management & Research Company LLC11.4%
  • Pontifax Venture Capital9.1%
  • UBS Financial Services, Inc.5.9%
  • Next 6 largest institutions23.7%
  • All other shareholders32.3%
Top institutional holders of CLYM
HolderShares% of shares
RA Capital Management, LP10.06M17.57%
Fidelity Management & Research Company LLC6.52M11.39%
Pontifax Venture Capital5.21M9.09%
UBS Financial Services, Inc.3.40M5.95%
Braidwell LP2.80M4.89%
Adage Capital Management, L.P.2.51M4.38%
BlackRock Institutional Trust Company, N.A.2.15M3.75%
Cormorant Asset Management, LP2.11M3.68%
T. Rowe Price Associates, Inc.2.10M3.66%
Frontier Capital Management Company, LLC1.94M3.39%

Largest mutual fund holders

Top mutual fund holders of CLYM
HolderShares% of shares
Fidelity Small Cap Growth Fund1.80M3.14%
T. Rowe Price Health Sciences Fund1.64M2.86%
Vanguard Total Stock Market Index Fund1.37M2.39%
Fidelity Stock Selector Small Cap Fund1.19M2.08%
Fidelity Advisor Biotechnology Fund996.40K1.74%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $1.37M (1 trade) of CLYM on the open market, with no buys.

Latest CLYM insider transactions
InsiderTypeSharesValue
Thomas Stephen BasilSale100.00K$1.37M
Celebi Breanna MaurineAward70.28K—
RA CAPITAL MANAGEMENT, L.P.Award70.28K—
Levin Andrew DavidAward40.00K—
Thomas Stephen BasilAward40.00K—
Dunn JudithAward40.00K—
Cumbo AlexanderAward40.00K—
Drapkin Kimberlee CAward40.00K—
RA Capital Healthcare Fund LPAward40.00K—
WILLIAMS DOUGLAS EAward40.00K—

Short interest

Settled Sep 30, 2026

Shares short
9.72M
Days to cover
5.64
% of shares outstanding
16.97%
Average daily volume
1.72M
Change since last report
+14.2%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.